BPC 157 (Body Protection Compound 157) Peptide for Tissue Repair & R ELITE BIO COMPOUNDS BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog